price
YD
NASDAQ · YDES
YD Bio Limited Ordinary Shares
Healthcare · Biotechnology
$4.69
Down-$0.10 (-2.00%)
Updated Aug 22, 2026, 8:08 AM
SID Score
4.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 894.92M
- P/E ratio
- -14.54
- Dividend yield
- 0.00%
- 52-week range
- $1.70 – $8.77
- Volume
- 36.01K
- Avg. volume
- 92.84K
Price performance
YDES price history
1M range · 21 trading sessions · Daily adjusted prices
YDES closed at $4.69 after 21 trading sessions, up 109.38% for the selected period.
- Last close
- $4.69
- Period change
- +109.38%
- Period low
- $2.17
- Period high
- $4.79
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $4.56 | $5.00 | $4.40 | $4.69 | 36.01K |
| Aug 20, 2026 | $4.39 | $4.99 | $4.0091 | $4.7858 | 105.12K |
| Aug 19, 2026 | $3.94 | $4.55 | $3.6001 | $4.47 | 83.94K |
| Aug 18, 2026 | $3.50 | $4.00 | $3.38 | $3.98 | 87.78K |
| Aug 17, 2026 | $3.11 | $3.40 | $2.79 | $3.37 | 64.6K |
| Aug 14, 2026 | $2.76 | $3.2399 | $2.415 | $2.98 | 73.61K |
| Aug 13, 2026 | $2.69 | $2.77 | $2.39 | $2.51 | 16.31K |
| Aug 12, 2026 | $2.79 | $2.80 | $2.58 | $2.60 | 22.05K |
| Aug 11, 2026 | $2.54 | $2.75 | $2.50 | $2.73 | 21.09K |
| Aug 10, 2026 | $2.275 | $2.57 | $2.1701 | $2.505 | 35.35K |
| Aug 7, 2026 | $2.55 | $2.5583 | $2.23 | $2.295 | 27.71K |
| Aug 6, 2026 | $2.35 | $2.49 | $2.21 | $2.3641 | 20.08K |
| Aug 5, 2026 | $2.25 | $2.395 | $2.25 | $2.25 | 23.96K |
| Aug 4, 2026 | $2.28 | $2.435 | $2.28 | $2.32 | 5.5K |
| Aug 3, 2026 | $2.35 | $2.46 | $2.21 | $2.30 | 142.89K |
| Jul 31, 2026 | $2.35 | $2.38 | $2.16 | $2.17 | 10.13K |
| Jul 30, 2026 | $2.26 | $2.38 | $2.11 | $2.20 | 28.82K |
| Jul 29, 2026 | $2.31 | $2.31 | $2.10 | $2.269 | 14.62K |
| Jul 28, 2026 | $2.29 | $2.60 | $2.18 | $2.30 | 42.64K |
| Jul 27, 2026 | $2.21 | $2.37 | $2.17 | $2.29 | 25.94K |
| Jul 24, 2026 | $2.44 | $2.44 | $1.96 | $2.24 | 83.14K |
Latest YDES news
The latest Smart Investors Daily articles mentioning YDES.
Stock researchResearch & News · Analysis
Loading stock research…

